[HTML][HTML] A randomized trial of topical fibrinogen-depleted human platelet lysate treatment of dry eye secondary to chronic graft-versus-host disease
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease
Cambium Dry Eye Study Group - Ophthalmology Science, 2022 - ohsu.elsevierpure.com
Purpose: The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease
Cambium Dry Eye Study Group - Ophthalmology Science, 2022 - experts.umn.edu
Purpose: The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease
A Sugar, M Hussain, W Chamberlain… - Ophthalmology …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
[HTML][HTML] A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease
A Sugar, M Hussain, W Chamberlain… - Ophthalmology …, 2022 - ncbi.nlm.nih.gov
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
[HTML][HTML] A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease
A Sugar, M Hussain, W Chamberlain… - Ophthalmology …, 2022 - ophthalmologyscience.org
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.
A Sugar, M Hussain, W Chamberlain, R Dana… - Ophthalmology …, 2022 - europepmc.org
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.
A Sugar, M Hussain, W Chamberlain, R Dana… - Ophthalmology …, 2022 - europepmc.org
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …